Outpatient teclistamab step-up dosing in Multiple Myeloma
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a recent article by Tyler B. Sandahl on X:
“Great to see in JCO Oncology Practice – Mayo experience with outpatient teclistamab step-up dosing in Multiple Myeloma.
This is where the field is headed, and impressive to see how quickly Mayo Myeloma campuses moved there and how much this time toxicity for patients.”
Authors: Tyler B. Sandahl, Scott A. Soefje, Rafael Fonseca, Sikander Ailawadhi, Ricardo Parrondo, Dee Lin, Bingcao Wu, Ediz S. Calay, Eli Silvert, Nina Kim, Corinne Carpenter, Tyler E. Wagner, Jessica Fowler, Laura Hester, Nivedita Rangarajan, Karthik Murugadoss, Alexander Marshall, Patrick Stoy, Dina Gifkins, Yi Li and Shaji Kumar
Rahul Banerjee is an assistant professor at Fred Hutchinson Cancer Center at the University of Washington. He completed his residency at the University of Pennsylvania health system.
He completed his fellowship in haematology and oncology from the University of California, San Francisco. He has authored over 70 peer-reviewed publications. His clinical interests include multiple myeloma.
More posts featuring Rahul Banerjee.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023